X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205775
https://www.prnewswire.com/news-releases/breckenridge-announces-final-approval-of-its-anda-for-everolimus-tablets-generic-for-afinitor-301242556.html#:~:text=BERLIN%2C%20Conn.%2C%20March%208,(generic%20for%20Afinitor%C2%AE).
https://www.prnewswire.com/news-releases/breckenridge-announces-final-approval-of-its-anda-for-everolimus-tablets-generic-for-afinitor-301242556.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212936
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207486
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212936
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210050
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207934
https://www.fiercebiotech.com/research/improving-kras-inhibitors-lung-cancers-a-combo
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207934
https://www.patentdocs.org/2019/05/novartis-pharmaceuticals-corp-v-west-ward-pharmaceuticals-intl-fed-cir-2019.html
https://www.reuters.com/article/us-novartis-afinitor-lawsuit/novartis-defeats-challenge-to-validity-of-afinitor-patent-idUSKCN1SL059?feedType=RSS&feedName=healthNews
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210130
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210050
http://www.pharmatimes.com/news/nhs_to_fund_afinitor_for_tsc-related_epilepsy_1273613
https://www.fiercebiotech.com/biotech/az-drops-mid-stage-cancer-drug-vistusertib
https://www.ema.europa.eu/documents/product-information/kisplyx-epar-product-information_en.pdf
https://www.ema.europa.eu/documents/procedural-steps-after/afinitor-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
http://www.pharmatimes.com/news/lenvima_wins_green_light_in_liver_cancer_1249253
https://www.pharmacompass.com/pdf/news/generic-unprecedented-approved-for-the-treatment-of-cancer-1532669634.pdf
https://www.fiercepharma.com/marketing/novartis-app-to-support-net-cancer-community-gets-apple-featured-boost
http://www.pharmatimes.com/news/novartis_afinitor_disperz_wins_new_tsc-related_approval_1231337
https://www.prnewswire.com/news-releases/tuberous-sclerosis-alliance-salutes-fda-approval-of-afinitor-disperz-everolimus-as-the-first-adjunctive-treatment-approved-in-us-for-patients-aged-2-years-and-older-with-tuberous-sclerosis-complex-tsc-associated-partial-onset-300627808.html
https://globenewswire.com/news-release/2018/02/08/1336104/0/en/Rexahn-Pharmaceuticals-Announces-Collaboration-with-Zhejiang-Haichang-Biotechnology-Co-Ltd-for-the-Development-of-RX-0201-Archexin-for-the-treatment-of-Hepatocellular-Carcinoma.html
http://www.moneycontrol.com/news/business/companies/us-fda-issues-guidelines-to-help-generic-makers-to-copy-32-complex-drug-products-2416811.html
https://www.tga.gov.au/prescription-medicines-new-or-extended-uses-registered-medicines
http://www.pharmatimes.com/news/nice_backs_afinitor,_sutent_for_neuroendocrine_tumours_1197308
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207934
http://www.pharmatimes.com/news/ipsen_in_talks_with_nice_over_cabometyx_rejection_1191548
https://www.pharmacompass.com/pdf/news/afinitor-everolimus-novartis-v-breckenridge-pharmaceuticals-1494838474.pdf
https://www.pharmacompass.com/pdf/news/afinitor-disperz-everolimus-novartis-v-mylan-pharmaceuticals-1494838651.pdf
https://www.pharmacompass.com/pdf/news/afinitor-everolimus-novartis-v-teva-pharmaceuticals-1494838513.pdf
http://www.pharmatimes.com/news/novartis_afinitor_gets_nice_green_light_for_kidney_cancer_1187413
http://www.reuters.com/article/us-novartis-votubia-idUSKBN15F0H6
http://www.pharmatimes.com/news/nice_recommends_novartis_kidney_cancer_drug_1183969
https://globenewswire.com/news-release/2016/12/16/898359/0/en/Novartis-drug-Votubia-recommended-by-CHMP-for-EU-approval-to-treat-refractory-partial-onset-seizures-in-patients-with-TSC.html
http://www.pharmatimes.com/news/nice_reappraisals_back_novartis_afinitor_and_pfizers_xalkori_1176235
http://www.pharmatimes.com/news/smc_endorses_use_of_five_meds_on_nhs_scotland_1175885
http://www.pmlive.com/pharma_news/nice_u-turn_on_opdivo_for_kidney_cancer_1172975
http://www.pharmatimes.com/news/nice_shoots_down_two_cdf_drugs_1102601
http://www.biospectrumasia.com/biospectrum/news/224059/eisai-receives-positive-chmp-opinion-indication-anticancer-agent
www.prnewswire.com/news-releases/novartis-announces-us-collaboration-to-co-promote-lenvima-in-combination-with-everolimus-for-advanced-renal-cell-carcinoma-rcc-300279055.html
http://www.prnewswire.com/news-releases/novartis-drug-afinitor-significantly-reduces-seizures-in-phase-iii-study-of-patients-with-tuberous-sclerosis-complex-300254627.html
Market Place
Share 
